Tai Chi Mind-Body Therapy for Fibromyalgia: a Pilot Single-Blind Randomized Controlled Trial.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Fibromyalgia
- Sponsor
- Tufts Medical Center
- Enrollment
- 66
- Locations
- 1
- Primary Endpoint
- Mean Change From Baseline of Fibromyalgia Impact Questionnaire Score
- Status
- Completed
- Last Updated
- 10 years ago
Overview
Brief Summary
The purpose of this study is to obtain preliminary data on the effects of Tai Chi on musculoskeletal pain, fatigue, sleep quality, psychological distress, physical performance,and health status in 60 patients with fibromyalgia.
Detailed Description
Fibromyalgia (FM) is a common, complex chronic condition marked by diffuse musculoskeletal pain, fatigue, functional impairment, disability, and psychological distress that affects 6-10 million people in the United States (US). There are currently no satisfactory pharmacological or non-pharmacological treatments for FM. New cost-effective strategies that reduce musculoskeletal pain and improve emotional and physical functioning as well as quality of life in people with FM are urgently needed. Tai Chi is a traditional Chinese discipline with both physical and mental components that appears to benefit a variety of chronic conditions. The physical component provides exercise that is consistent with that recommended for FM (muscle conditioning and aerobic cardiovascular exercise), while the mental component has the potential to improve psychological well-being. These effects are especially pertinent for the treatment of individuals with FM. This is a pilot randomized controlled trial of Tai Chi for fibromyalgia. We plan to enroll 60 patients with fibromyalgia over a two year period. Participants are randomized to either a Tai Chi program or an attention control intervention. Assessments are performed at baseline, week 12 and week 24. This study will provide preliminary data on the potential acceptability and safety of Tai Chi for FM and will help guide the design of a future large-scale study of the efficacy of this alternative therapy.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age 21 or older
- •Fulfills the American College of Rheumatology (ACR) 1990 diagnostic criteria for FM. (1) a history of widespread musculoskeletal pain on the right and left sides of the body as well as above and below the waist for a minimum duration of 3 months, and (2) pain in 11 or more of 18 specific tender points with moderate or greater tenderness reported upon digital palpation.
- •Physically able to participate in both the Tai Chi and stretching and education programs according to their primary care physician.
- •Willing to complete the 12-week study, including twice-a-week Tai Chi or stretching and education sessions
- •Exclusion Criteria
- •Prior experience with Tai Chi or other similar types of Complementary and Alternative Medicine in the past 6 months such as Qi gong and yoga since these share some of the principles of Tai Chi
- •Any health condition limiting the ability to participate as determined by a primary care physician
- •Any other diagnosed medical condition that is known to contribute to FM symptomatology that is not under adequate control or cannot be expected to remain under adequate control for the study period such as thyroid disease, inflammatory arthritis, scleroderma, systemic lupus erythematosus, systemic sclerosis, rheumatoid arthritis, myositis and vasculitis or Sjogren's syndrome
- •Not English-Speaking
- •Positive pregnancy test or planning pregnancy within the study period
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Mean Change From Baseline of Fibromyalgia Impact Questionnaire Score
Time Frame: wks 12
Fibromyalgia Impact Questionnaire (FIQ) is a well-validated, multidimensional measure of the overall severity of fibromyalgia as rated by patients. Categories include the intensity of pain, physical functioning, fatigue, morning tiredness, stiffness, depression, anxiety, job difficulty, and overall well-being.21 The total score ranges from 0 to 100, with higher scores indicating more severe symptoms.
Secondary Outcomes
- Mean Change From Baseline SF-36 Score Mental Component(12 weeks)
- Mean Change From Baseline of VAS Physicians' Global Assessment of Fibromyalgia Severity(Wks 12)
- Mean Change From Baseline of Patient's Global Assessment Score(12 weeks)
- Mean Change From Baseline PSQI Score(12 weeks)
- Mean Change From Baseline of 6-Minute Walk Test(12 weeks)
- Mean Change From Baseline SF-36 Score Physical Component(12 weeks)
- Mean Change From Baseline CES-D Score(12 weeks)
- Mean Change From Baseline CPSS Score(12 weeks)